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Introduction
The biogenesis of membrane oligomeric complexes of the mitochondrial respiratory chain is an intricate process that requires the co-assembly of mitochondrial and nuclear encoded subunits and the participation of nuclear-encoded factors that are not intrinsic components of the complex. Most of these proteins are conserved through evolution and several human neurodegenerative pathologies are due to respiratory complex assembly defects.
Oxa1p is functionally conserved from bacteria to eukaryotic organelles and is a key component of the insertion machinery of membrane subunits. In the yeast Saccharomyces cerevisiae, the deletion of OXA1 impairs the biogenesis of the three respiratory complexes of dual genetic origin (complex III, IV and V) and the membrane subunits are rapidly degraded (Bonnefoy et al., 1994; Altamura et al., 1996; Lemaire et al., 2000) . Moreover, Oxa1p seems essential for the translocation of the hydrophilic domain of the complex IV subunit, Cox2p (He and Fox, 1997; Hell et al., 1997; Herrmann and Bonnefoy, 2004) . Oxa1p interacts with nascent mitochondrial polypeptides (Hell et al., 2001) and its C-terminal tail located in the mitochondrial matrix binds the mitochondrial ribosome. This interaction has been proposed to mediate the co-translational insertion of mitochondrially encoded subunits (Szyrach et al., 2003; Jia et al., 2003) . Oxa1p show an N-out C-in topology (Herrmann et al., 1997) with three domains located in the intermembrane space, the inner membrane and the matrix. In order to clarify the precise role of these domains, we have constructed point and deletion mutants (Lemaire et al., 2004) and we have undertaken a systematic search for suppressors able to compensate for the respiratory deficiency due to various oxa1 mutations.
We have already isolated two classes of extragenic suppressors able to compensate the respiratory deficiency of oxa1 mutants. First, suppressor mutations located in the trans-membrane (TM) domains of two subunits of complex III, Cyt1p and Qcr9p, are able to compensate for the absence of Oxa1p (Doxa1). We have proposed that these mutated TM domains of Cyt1p or Qcr9p could interact with the TM domains of other respiratory complex subunits leading to an insertion process independent of Oxa1p (Hamel et al., 1998; Saint-Georges et al., 2001) . Second, the high copy suppressor gene, OMS1, encoding a methyl-transferase like protein, is specific for some oxa1 alleles. The overexpression of OMS1 increases the steady-state level of Oxa1p and thus facilitates the membrane insertion of respiratory subunits. This stabilization of Oxa1p could result from modifications of Oxa1p residues or of phospholipids (Lemaire et al., 2004) . Thus, the suppression mechanisms are both acting at the assembly level but appear completely different in both cases.
In this paper, we describe the characterization of a new high copy suppressor of an oxa1 mutation. We show that the suppressor gene corresponds to the transcriptional activator Hap4p which is known to regulate respiratory functions.
Materials and methods

Strains, media and genetic techniques
All strains were derived from the W303 nuclear background MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100. The oxa1 mutants were described in Lemaire et al. (2004) . The Dafg3 strain (afg3::HIS3) and the Dhap4 (hap4::G418) strain are from A. Tzagoloff and B. Guiard. Yeast genetic methods and media used for S. cerevisiae have been described in Dujardin et al. (1980) . Glucose or galactose were used as fermentable carbon sources and glycerol as a respiratory carbon source. Yeast cells were transformed by the lithium acetate procedure of Schiestl and Gietz (1989) for library screening.
High copy suppressor isolation
The oxa1 mutant was transformed with a high copy library constructed by F. Lacroute into the URA3 2A vector pFL44L. [Ura + ] clones were selected and replica-plated onto glycerol medium at 36 -C. Total yeast genomic DNA was extracted from fast or slow-growing co-segregating [Gly+] clones and used to transform Escherichia coli cells to recover the plasmids. Molecular analysis by restriction enzymes and sequencing identified the chromosomal fragments present in each plasmid.
Epitope tagging of Oxa1p
Oxa1p was tagged at its C-terminus with a six histidine epitope using the Saccharomyces pombe HIS5 marker gene as described in Longtine et al. (1998) . The PCR fragment was used to transform the starting strain to histidine prototrophy in order to fuse the tag to the end of the OXA1 ORF in the yeast genome. Correct integration was confirmed by PCR amplification and sequencing. The strain CWOXA expressing the tagged protein is respiratory competent at 28 -C and 36 -C showing that the tagged protein is fully functional.
Isolation of mitochondria, Western blotting
Mitochondria were purified following the differential centrifugation procedures after digestion of cell walls by Zymoliase-100T (Kermorgant et al., 1997) . The mitochondrial protein concentration was determined using the Bio-Rad assay. Mitochondrial proteins were separated on 12% acrylamide gels and blotted onto nitrocellulose membranes. Western blots were probed with various antibodies using the standard chemi-luminescence method.
Results and discussion
3.1. Over-expression of HAP4 compensates for the respiratory deficiency of oxa1-DL1-K332* mutant
In the search for genetic interactions involving the OXA1 gene, we decided to search for high copy suppressor genes able to alleviate the respiratory defect of oxa1 mutants. In oxa1-DL1-K332*, the Oxa1p variant presents a large deletion of the first loop (L1) and a premature stop codon at position 332 in the C-terminal tail; both these domains protrude into the matrix. This mutant presents a tight respiratory deficiency associated to a strong defect in complex IV assembly and activity and a much weaker effect on complexes III and V (Lemaire et al., 2004) . Three plasmids carrying overlapping fragments of chromosome XI (see Fig. 1A and B) were able to compensate for the respiratory deficiency of the mutation oxa1-DL1-K332*. By subcloning the larger 7-kb insert of YEpSu1 (YEPSu1A and YEPSu1B), we demonstrated that the HAP4 gene was responsible for the suppression. Surprisingly, the 4-kb fragment present in YEpSu8 and YEpSu22 exhibits a truncated HAP4 gene encoding a 471residue protein lacking the last 83 amino acids when compared to the full-length Hap4p. However, the overexpression of this truncated gene (HAP4-S allele) is as active in suppression as the complete HAP4 gene.
Hap4p is responsible for the transcriptional activation capability of the Hap2/3/4/5 complex that positively regulates many of the genes involved in respiratory functions (Forsburg and Guarente, 1989) . According to Bourgarel et al. (1999) and Stebbins and Triezenberg (2004) , there is, in the C-terminal part of Hap4p, an activation domain that extends from the positions 450 to 471. In order to determine if the last 83 amino acids were required for the Hap4p activity, we have transformed the Dhap4 strain with the plasmid carrying the truncated HAP4-S gene. As shown in Fig. 2 , the HAP4-S gene is able to fully complement the respiratory defect of the Dhap4 strain.
Thus, the last 83 amino acids of Hap4p appear dispensable for both suppression and complementation.
Specificity of the suppression by over-expression of HAP4
We have compared the suppression efficiency of HAP4 to the previously isolated suppressors (see Fig. 1B ). The suppressor mutation CYT1-1 is able to compensate for the total absence of Oxa1p while the over-expression of OMS1 does not compensate for the absence of Oxa1p but suppresses partial oxa1 defects (Lemaire et al., 2004) . The over-expression of HAP4 is able to partially restore the growth of the oxa1-DL1-K332* mutant on respiratory substrates but cannot compensate for the respiratory defects observed in the null allele, Doxa1 (not shown). We have also tested the missense mutation oxa1-WW>AA which is clearly suppressed by CYT1-1 and OMS1. In this mutant, a pair of tryptophan residues (positions 128 -129) in or close to the first trans-membrane segment TM1, are replaced by a pair of alanine residues. The mutant oxa1-WW>AA exhibits a slight growth delay on respiratory medium at 28 -C and a tight respiratory deficiency at 36 -C associated to a strong reduction in complex IV activity (Lemaire et al., 2004) . The over-expression of HAP4 suppresses the growth delay at 28 -C but does not restore the respiratory capacity at 36 -C, even after extended incubation. Interestingly, the suppression of oxa1-DL1-K332* by HAP4 is also much weaker at 36 -C than at 28 -C (not shown). Thus, HAP4 is a high copy suppressor of partial oxa1 defects and this suppression appears more efficient at 28 -C. As Oxa1p is involved in the insertion of the membrane subunits of respiratory complexes, this effect of temperature could be due to temperature-dependent modifications of the mitochondrial membrane or protein folding.
3.3. HAP4 over-expression strongly increases the steadystate level of Cox2p in the oxa1-DL1-K332* mutant Lascaris et al. (2003) have shown that cells overexpressing HAP4 up-regulate genes involved in mitochondrial biogenesis and activity. In particular, in a genome-wide expression experiment, OXA1 mRNA appears induced about twofold by HAP4 over-expression even though the OXA1 promoter does not contain the consensus regulatory sequence of the Hap2/3/4 complex. As we have previously shown that increasing the level of mutated Oxa1p can compensate for its own defect (Lemaire et al., 2004) , HAP4 over-expression could be also responsible for an increase in the steady-state level of Oxa1p. In order to test this hypothesis, we have used a strain with a tagged form of Oxa1p (see Materials and methods) and transformed this strain with the high copy plasmid carrying the HAP4 gene (YEpSu1) or the empty plasmid (pFL44L) and purified ∆ ∆ hap4 vector HAP4-S HAP4 glu gly YEpSu1, YEpSu8 and YepSu22 were obtained after transformation of the oxa1 mutant by the high copy library in pFL44 (see Materials and methods); YEpSu22 is identical to YEpSu8. YEpSu1A and YEpSu1B were obtained by sub-cloning YEpSu1 using the sites BamH1 and Pml1. The mutant cells were transformed with these different plasmids and the respiratory growth of transformants was tested as described in panel (B).+ respiratory growth; À no growth. (B) The oxa1-DL1-K332* mutant was transformed with six plasmids : YEp30 carrying the OXA1 gene, the empty control vector pFL44, the YEpSu1 and YEpSu8 plasmids expressing the truncated (HAP4-S) and full-length HAP4 gene, YEpPH66 carrying the CYT1-1 genetic suppressor (Hamel et al., 1998) and pNB212 carrying the high copy suppressor OMS1 (Lemaire et al., 2004) , respectively. The cells were patched on minimal glucose medium lacking uracil (Glu), replicaplated on non-fermentable substrate (Gly) and incubated at 28 -C for 10 days. The respiratory competent papillae correspond to genetic revertants. mitochondria from these transformants. As shown in Fig.  3A , we were not able to detect, in the strain over-expressing HAP4, any significant increase in the state-level of Oxa1p as compared to Arg8p. Arg8p is a mitochondrial protein not involved in respiratory function and is not induced by HAP4 over-expression according to Lascaris et al. (2003) . In parallel, we have also transformed a mutant lacking the mitochondrial matrix protease Afg3p, with the plasmids carrying either HAP4, OXA1 or OMS1. Indeed, it is known that over-expression of OXA1 can restore growth of the Dafg3 mutant on respiratory substrates (Rep et al., 1996; Lemaire et al., 2004) . As shown in Fig. 3B , the Dafg3 mutant is not suppressed by the over-expression of HAP4 while over-expression of OXA1 or OMS1 which increases the Oxa1p level (Lemaire et al., 2004) clearly restores respiratory growth under the same conditions. Altogether, these experiments suggest that the suppression via HAP4 is not due to an increased steady-state level of Oxa1p.
Hap4p positively regulates the expression of several genes involved in mitochondrial respiratory functions (Forsburg and Guarente, 1989) . Interestingly enough, Northern analyses have shown that the over-expression of HAP4 significantly increases the steady-state level of COX2 mRNA (Lascaris et al., 2003) . The oxa1-DL1-K332* mutant exhibits a pleiotropic defect in respiratory complex assembly and activity. In particular, the assembly of complex IV and the steady-state level of Cox2p are strongly decreased (Lemaire et al., 2004) . Thus, the HAP4 effect on COX2 could be responsible for the suppression effect. We have analysed the level of Cox2p in the oxa1-DL1-K332* mutant transformed either with the high copy plasmid carrying the HAP4 or the OXA1 gene. As shown in Fig. 4 , the steadystate level of Cox2p is very strongly increased by HAP4 over-expression in the oxa1-DL1-K332* mutant as compared to the effect on the level of Arg8p. The steady-state level of Atp4p is also slightly but reproducibly increased (150%) by HAP4 over-expression.
Conclusion
Whilst it is clear that the over-expression of a wild-type or truncated HAP4 gene is able to suppress the respiratory defect of the oxa1-DL1-K332* mutant but does not compensate for the absence of Oxa1p, the mechanism of this suppression remains to be elucidated. The over-expression of HAP4 does not seem to increase the steady-state level of Oxa1p but leads to a strong increase in the level of Cox2p in the oxa1-DL1-K332 mutant. This increase could explain the restoration of respiratory functions as a reduction in complex IV assembly and activity is the principal defect in the oxa1-DL1-K332* mutant. As Cox2p is encoded in the mitochondrial genome, it is probable that the effect of Hap4p is indirect. The increase in the level of Cox2p may be sufficient to explain the suppressor effect; alternatively, the suppression may be due to a combination of the increase of Cox2p and an increase in 
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Arg8p A B Fig. 3 . HAP4 over-expression does not lead to a significant increase in Oxa1p accumulation. (A) The CWOXA strain expressing a histidine tagged form of Oxa1p (see Materials and methods) was transformed with the YEpSu1 plasmid over-expressing HAP4 and the empty vector. Mitochondria were purified from transformants grown in minimal galactose medium for plasmid selection. Mitochondrial proteins (80 Ag) were analyzed by Western blotting (12% acrylamide gel) using the anti-his (Tetrahis, Quiagen) and the anti-Arg8 (T.D. Fox) antibodies. B) The Dafg3 mutant was transformed with high copy plasmids carrying the OXA1, HAP4 or OMS1 genes or with the empty vector and the respiratory growth was tested as in panel B of Fig. 1 .
the level of other mitochondrial proteins whose transcription is controlled by Hap4p. This suppression clearly differs from those previously reported for the CYT1-1 and OMS1 suppressors that act at a post-translational level of respiratory complex biogenesis. Tight interactions exist between the synthesis and assembly of respiratory complex subunits in mitochondria and are essential for the biogenesis of mitochondrial respiratory complexes. They are mediated through membrane-bound translational activators (Sanchirico et al., 1998) and the matrix C-terminal part of Oxa1p that was shown to interact with ribosomes (Szyrach et al., 2003; Jia et al., 2003) . Overexpression of HAP4 suppresses the oxa1-DL1-K332* mutant that exhibits a large deletion of the matrix domain of Oxa1p. Thus, it is tempting to propose that the increase in the expression of respiratory subunits compensate for the defect in co-translational membrane insertion of these subunits due to the oxa1 mutation.
